G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (Trilaciclib).

Biotechnology

G1 Therapeutics

G1 Therapeutics' headquarters in NC, United States

Zaida Padron

Raj Malik

Olu O. Oyeneye

Monica Thomas

Mike Townsend

Bobirjon Mukamilov

Maggie Gagnon

Glenn P. Muir

Jacks Lee

Norman E. Sharpless

The Oncology Sales and Marketing team at G1 Therapeutics is responsible for driving the commercial success of the company's oncology products, including COSELA™. This team manages relationships with healthcare providers, develops and implements marketing strategies, and ensures access to therapies for patients. Their collaborative efforts focus on educating stakeholders about product benefits, enhancing market presence, and optimizing distribution to improve patient outcomes in cancer treatment.

Oncology Sales and Marketing

The Marketing and Communications team at G1 Therapeutics is responsible for developing and executing strategic marketing initiatives to promote the company’s cancer therapies, including COSELA™. This team focuses on creating meaningful communication strategies for healthcare providers, patients, and investors, enhancing brand awareness, and driving engagement through targeted campaigns and corporate communications efforts. They work closely with sales, investor relations, and business development to ensure cohesive messaging and maximize impact in the biopharmaceutical market.

Marketing and Communications

The Leadership Team at G1 Therapeutics drives the strategic vision and operational execution of the company, ensuring alignment with its mission to innovate cancer therapies. Comprising key executives including the CEO, Chief Medical Officer, and Chief Business Officer, the team oversees clinical development, business strategies, and commercial initiatives to advance the company’s portfolio and maximize the impact of COSELA™ and future products on patient care.

Leadership Team

The Analytics and Development team at G1 Therapeutics leverages data analytics and strategic insights to support the commercialization of innovative cancer therapies. This team collaborates across departments to optimize operational efficiency, enhance decision-making through statistical programming, and ensure robust financial planning and analysis to drive the company's growth and success in the biopharmaceutical landscape.

Analytics and Development

The Legal and Compliance team at G1 Therapeutics ensures that the company adheres to all legal and regulatory requirements while navigating the complexities of the biopharmaceutical industry. They provide legal guidance on corporate governance, compliance issues, and regulatory affairs, supporting the development and commercialization of innovative cancer therapies. Their work helps safeguard the company's interests and maintains the integrity of its operations.

Legal and Compliance

The Clinical Operations Team at G1 Therapeutics is responsible for overseeing and managing clinical trials to assess the safety and efficacy of cancer therapies. This team coordinates between various stakeholders, including regulatory bodies and research facilities, to ensure compliance with clinical protocols and timelines. They play a crucial role in data collection and analysis, facilitating the effective development and delivery of the company’s innovative treatments like COSELA™.

G1 Therapeutics

Org chart

Board & advisors

Teams

Oncology Sales and Marketing

Marketing and Communications

Leadership Team

Analytics and Development

Legal and Compliance

Clinical Operations Team

Offices

G1 Therapeutics

Org chart

Board & advisors

Teams

Oncology Sales and Marketing

Marketing and Communications

Leadership Team

Analytics and Development

Legal and Compliance

Clinical Operations Team

Offices

Related companies